Sign In
Buy BNTX
$90.58
-2.27 (-2.44%)
At Close: Jul 31, 2026
BioNTech SE (BNTX) Q3 2025 Earnings Call Transcript
12:46pm, Monday, 03'rd Nov 2025
BioNTech SE ( BNTX ) Q3 2025 Earnings Call November 3, 2025 8:00 AM EST Company Participants Douglas Maffei Ugur Sahin - Co-Founder, CEO & Chair of the Management Board Özlem Türeci - Co-Founder, Ch
BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership
10:29am, Monday, 03'rd Nov 2025
BioNTech SE (NASDAQ:BNTX) reported a third-quarter per-share loss of 14 cents (12 cents in euros) on Monday, a turnaround from earnings of 81 cents reported a year ago, missing the consensus earnings
BioNTech lifts 2025 revenue guidance on BMS partnership payment
06:47am, Monday, 03'rd Nov 2025
Germany's BioNTech on Monday lifted its 2025 revenue guidance after receiving initial payments from its new partner Bristol Myers Squibb in a cancer immunotherapy alliance that seeks to challenge Merc
BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update
06:45am, Monday, 03'rd Nov 2025
Continued clinical execution of oncology strategy with focus on two pan-tumor programs, including combination approaches to address the full continuum of cancer from early to late disease stages Demon
BioNTech to Host Innovation Series R&D Day on November 11, 2025
07:45am, Tuesday, 28'th Oct 2025
MAINZ, Germany, October 28 , 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”), will host an edition of the Company's Innovation Series R&D Day at 09:00 a.m. Ea
BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025
07:45am, Monday, 27'th Oct 2025
MAINZ, Germany, October 27, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2025 on Monday, November
BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.
06:45am, Wednesday, 22'nd Oct 2025
MAINZ, Germany, October 22, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced it had commenced its public exchange offer (the “Offer”) for all outstanding shar
Liquidia Technologies (NASDAQ:LQDA) vs. BioNTech (NASDAQ:BNTX) Financial Comparison
01:48am, Wednesday, 22'nd Oct 2025
BioNTech (NASDAQ: BNTX - Get Free Report) and Liquidia Technologies (NASDAQ: LQDA - Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses ba
Moderna Vs BioNTech: Who's Winning The Post-COVID Race
09:30am, Saturday, 18'th Oct 2025
Moderna and BioNTech were the main 'saviors' of people and economies from COVID-19. However, since the pandemic ended, their stock prices have fallen by more than 70%. Recognizing this, BioNTech and M
Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead
10:15am, Wednesday, 08'th Oct 2025
On Sept. 30, Pfizer announced a deal with the U.S. government that will allow the pharmaceutical leader to avoid President Donald Trump's tariffs for three years in exchange for slashing the prices of
BioNTech SE, InstaDeep Ltd - Special Call
06:52pm, Wednesday, 01'st Oct 2025
BioNTech SE, InstaDeep Ltd - Special Call Company Participants Ugur Sahin - Co-Founder, CEO & Chair of the Management Board Karim Beguir Alexandre Laterre Bernardo Almeida Bora Guloglu Nicolas Lopez C
Why BioNTech Stock Jumped by Nearly 4% on Wednesday
06:13pm, Wednesday, 01'st Oct 2025
Germany-based BioNTech (BNTX 3.64%) saw its U.S. listed stock enjoy a mini-pop on Wednesday, and for once this wasn't largely based on the Comirnaty COVID-19 vaccine it developed with Pfizer. Rather,
BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025
06:45am, Tuesday, 23'rd Sep 2025
MAINZ, Germany, September 23, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”), alongside its artificial intelligence (“AI”) company InstaDeep Ltd. (“InstaDeep”), will host
Why BioNTech Stock Bumped Higher Today
06:45pm, Monday, 22'nd Sep 2025
A victory on the regulatory front and a bullish analyst move were the twin news items propelling BioNTech's (BNTX 2.52%) shares higher as the stock trading week began on Monday. The Germany-based biot
Mizuho's Jared Holz: There's not much value left in vaccine stocks
11:40am, Friday, 19'th Sep 2025
Jared Holz, Mizuho healthcare senior strategist, joins CNBC's 'Squawk on the Street' to discuss outlooks on pharmaceuticals, what new government vaccine panel recommendations mean for the stocks, and
